Bayer hit with $3.3b Roundup verdict in US cancer | Australian Markets
A US jury has ordered German pharmaceutical giant Bayer to pay about $US2.1 billion ($A3.3 billion) to a plaintiff who claimed the company’s Roundup weed killer precipitated his cancer, the sufferer’s law firm says
The verdict in the US state of Georgia, which Bayer stated on Saturday it could appeal, is one of the biggest legal settlements issued in a Roundup-related case and is the latest setback for the group, among the many world’s largest seeds and pesticide makers.
Bayer has paid about $US10 billion ($A16 billion) to settle disputed claims that Roundup, based mostly on the herbicide glyphosate, causes cancer.
More than 60,000 additional circumstances are pending for which the group has set apart $US5.9 billion ($A9.4 billion) in legal provisions.
The German pharmaceutical and biotechnology group acquired Roundup as half of its $US63 billion ($A100 billion) takeover of US agrochemical company Monsanto in 2018.
The Georgia verdict consists of $US65 million ($A104 million) in compensatory damages and $US2 billion ($A3.2 billion) in punitive damages, in line with a assertion emailed to Reuters by the plaintiff’s law corporations Arnold & Itkin LLP and Kline & Specter PC.
Bayer stated in a assertion it disagreed with the jury’s verdict, because it conflicted with the overwhelming weight of scientific proof and the consensus of regulatory our bodies and their scientific assessments worldwide.
“We believe that we have strong arguments on appeal to get this verdict overturned and the excessive and unconstitutional damage awards eliminated or reduced,” it stated.
It stated that damages in circumstances which have reached closing judgements have been lowered 90 per cent total in contrast with the unique jury awards.
Earlier this month, Bayer informed US lawmakers it may stop promoting Roundup except they strengthened legal safety in opposition to product legal responsibility litigation, a financial analyst and individual close to the matter informed Reuters.
Stay up to date with the latest news in the Australian markets! Our web site is your go-to source for cutting-edge financial news, market trends, financial insights, and updates on native trade. We present every day updates to make sure you have entry to the freshest data on Australian stock actions, commodity costs, currency fluctuations, and key financial developments.
Explore how these trends are shaping the long run of Australia’s economic system! Visit us usually for essentially the most partaking and informative market content material by clicking right here. Our fastidiously curated articles will keep you knowledgeable on market shifts, investment methods, regulatory modifications, and pivotal moments in the Australian financial panorama.
